rs140551719
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_001126108.2(SLC12A3):c.938C>T(p.Ala313Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000502 in 1,613,896 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001126108.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A3 | NM_001126108.2 | c.938C>T | p.Ala313Val | missense_variant | Exon 7 of 26 | ENST00000563236.6 | NP_001119580.2 | |
SLC12A3 | NM_000339.3 | c.938C>T | p.Ala313Val | missense_variant | Exon 7 of 26 | NP_000330.3 | ||
SLC12A3 | NM_001126107.2 | c.935C>T | p.Ala312Val | missense_variant | Exon 7 of 26 | NP_001119579.2 | ||
SLC12A3 | NM_001410896.1 | c.935C>T | p.Ala312Val | missense_variant | Exon 7 of 26 | NP_001397825.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A3 | ENST00000563236.6 | c.938C>T | p.Ala313Val | missense_variant | Exon 7 of 26 | 1 | NM_001126108.2 | ENSP00000456149.2 | ||
SLC12A3 | ENST00000438926.6 | c.938C>T | p.Ala313Val | missense_variant | Exon 7 of 26 | 1 | ENSP00000402152.2 | |||
SLC12A3 | ENST00000566786.5 | c.935C>T | p.Ala312Val | missense_variant | Exon 7 of 26 | 1 | ENSP00000457552.1 | |||
SLC12A3 | ENST00000262502.5 | c.935C>T | p.Ala312Val | missense_variant | Exon 7 of 26 | 5 | ENSP00000262502.5 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251358Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135876
GnomAD4 exome AF: 0.0000520 AC: 76AN: 1461654Hom.: 1 Cov.: 31 AF XY: 0.0000550 AC XY: 40AN XY: 727156
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74374
ClinVar
Submissions by phenotype
Familial hypokalemia-hypomagnesemia Pathogenic:5
- -
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Gitelman syndrome (MIM#263800). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from alanine to valine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (v2: 6 heterozygotes, 0 homozygotes). (SP) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0600 - Variant is located in the annotated AA_permease domain (DECIPHER). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. It has been reported in at least ten Gitelman Syndrome patients both as homozygous and compound heterozygous (PMID: 25012174, 22009145, 21415153, ClinVar). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
- -
ACMG criteria used:PS4 PM1 PM2 PP5 -
not provided Pathogenic:2
- -
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 313 of the SLC12A3 protein (p.Ala313Val). This variant is present in population databases (rs140551719, gnomAD 0.004%). This missense change has been observed in individual(s) with Gitelman syndrome (PMID: 11168953, 15824853, 21415153, 22009145). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 448400). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SLC12A3 protein function. For these reasons, this variant has been classified as Pathogenic. -
SLC12A3-related disorder Pathogenic:1
The SLC12A3 c.938C>T variant is predicted to result in the amino acid substitution p.Ala313Val. This variant has been reported in the homozygous or compound heterozygous state in patients with Gitelman syndrome (Table S1a, Vargas-Poussou et al. 2011. PubMed ID: 21415153; Cruz et al. 2001. PubMed ID: 11168953; Table S1, Hureaux et al. 2019. PubMed ID: 31672324). This variant is reported in 0.0040% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/16-56906348-C-T). This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at